化学
增溶
包涵体
药物开发
药品
结构基因组学
药物发现
计算生物学
组合化学
生物化学
大肠杆菌
蛋白质结构
药理学
生物
基因
作者
Xinli Lin,Tomomi Umetsu
标识
DOI:10.2174/138920110791111906
摘要
We have developed a high-pH, pH-shift refolding "Ph-Fold technology", both for academic research and industrial protein drug development applications. Using this technology, we were able to refold some "difficult-to-refold" proteins, some of which are proven important drug targets and protein drug candidates. The technology is composed of the initial E. coli production of inclusion bodies, the high pH solubilization/pH shift refolding screening technology, which includes automated pH shift refolding screening, and the methods of testing protein refolding without functional assay. This technology, especially the automated refolding system based on the Ph-Fold technology, may help both academic and industrial research in broadening structural genomic research, functional proteomics, and genomic scale drug development efforts.
科研通智能强力驱动
Strongly Powered by AbleSci AI